Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: UBS downgrades Persimmon and Crest Nicholson

Thu, 18th Mar 2021 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS CUTS BERKELEY GROUP PRICE TARGET TO 5,240 (5,475) PENCE - 'BUY'

----------

UBS CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 810 (840) PENCE - 'BUY'

----------

UBS RAISES TAYLOR WIMPEY PRICE TARGET TO 215 (210) PENCE - 'BUY'

----------

UBS CUTS PERSIMMON TO 'NEUTRAL' ('BUY') - TARGET 2,915 (3,070) PENCE

----------

MORGAN STANLEY RAISES FERGUSON TARGET TO 9,500 (9,060) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 10,200 (10,000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STANDARD LIFE ABERDEEN TO 'BUY' (HOLD) - TARGET 335 (310) PENCE

----------

BERENBERG CUTS LONDON STOCK EXCHANGE PRICE TARGET TO 10,000 (11,800) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS LSE PRICE TARGET TO 7,000 (9,100) PENCE - 'HOLD'

----------

BARCLAYS CUTS BAT PRICE TARGET TO 3,300 (3,800) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES NATWEST TO 'CONVICTION BUY LIST' ('BUY') - TARGET 300 (285) PENCE

----------

GOLDMAN RAISES LLOYDS PRICE TARGET TO 46 (42) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES FERGUSON PRICE TARGET TO 10,581 (10,046) PENCE - 'BUY'

----------

GOLDMAN RAISES BURBERRY PRICE TARGET TO 2,005 (1,690) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

UBS CUTS CREST NICHOLSON TO 'SELL' ('NEUTRAL') - TARGET 315 (320) PENCE

----------

UBS CUTS REDROW PRICE TARGET TO 810 (885) PENCE - 'BUY'

----------

UBS CUTS BELLWAY PRICE TARGET TO 3,780 (4,040) PENCE - 'BUY'

----------

UBS RAISES SAVILLS PRICE TARGET TO 1150 (850) PENCE - 'NEUTRAL'

----------

KEPLER CHEUVREUX RAISES RHI MAGNESITA TARGET TO 5,000 (4,000) PENCE - 'BUY'

----------

KEPLER CHEUVREUX CUTS SSP GROUP PRICE TARGET TO 300 (330) PENCE - 'HOLD'

----------

LIBERUM CUTS SSP GROUP PRICE TARGET TO 350 (375) PENCE - 'BUY'

----------

LIBERUM RAISES FERREXPO PRICE TARGET TO 510 (500) PENCE - 'BUY'

----------

BERENBERG RAISES NATIONAL EXPRESS PRICE TARGET TO 370 (360) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES SSP GROUP PRICE TARGET TO 400 (350) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES HAYS PRICE TARGET TO 170 (160) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES VIRGIN MONEY PRICE TARGET TO 205 (175) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES RICARDO PRICE TARGET TO 570 (550) PENCE - 'BUY'

----------

BERENBERG RAISES SENIOR PRICE TARGET TO 112 (85) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.